Analysis of different adipose depot gene expression in cachectic patients with gastric cancer

Abstract Purpose This study aimed to identify the differentially expressed genes (DEGs) that contributed to the different amount of fat loss between subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) among cachectic patients. Methods RNA sequencing was performed and bioinformatic to...

Full description

Bibliographic Details
Main Authors: Jun Han, Zuoyou Ding, Qiulin Zhuang, Lei Shen, Fan Yang, Szechun Sah, Guohao Wu
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Nutrition & Metabolism
Subjects:
Online Access:https://doi.org/10.1186/s12986-022-00708-x
_version_ 1798044535704518656
author Jun Han
Zuoyou Ding
Qiulin Zhuang
Lei Shen
Fan Yang
Szechun Sah
Guohao Wu
author_facet Jun Han
Zuoyou Ding
Qiulin Zhuang
Lei Shen
Fan Yang
Szechun Sah
Guohao Wu
author_sort Jun Han
collection DOAJ
description Abstract Purpose This study aimed to identify the differentially expressed genes (DEGs) that contributed to the different amount of fat loss between subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) among cachectic patients. Methods RNA sequencing was performed and bioinformatic tools were utilized to analyze the biological functions and construct regulation networks of DEGs. We presumed that iroquois homeobox 1 (IRX1) to be a hub gene and analyzed its clinical significance. Mouse model of cancer cachexia was established and differences between SAT and VAT were compared. The function of IRX1 on lipid metabolism was clarified by Oil Red O staining, qRT-PCR, and Western blotting in adipocytes. Results A total of 455 DEGs were screened between SAT and VAT in cachectic patients. Several hub genes were selected and IRX1 was presumed to contribute to the pathological difference between SAT and VAT in cancer cachexia. Patients with higher expression of IRX1 in SAT than VAT revealed significantly higher weight loss, IL-6 and TNF-α, as well as lower BMI, SAT, and VAT area. IRX1 expression in SAT was negatively correlated with SAT area. In cachectic mice, the expression of IRX1 in SAT was significantly higher than that in VAT. The inhibition effect on adipogenesis exerted by IRX1 was also proved in vitro. Conclusion These data supported that DEGs contribute to the different degrees of fat loss among adipose depots in cachectic patients. IRX1 in SAT promoted fat loss by inhibiting adipocyte differentiation and adipogenesis.
first_indexed 2024-04-11T23:05:46Z
format Article
id doaj.art-e32a2b1eea3b4671bd63e223af76c5eb
institution Directory Open Access Journal
issn 1743-7075
language English
last_indexed 2024-04-11T23:05:46Z
publishDate 2022-10-01
publisher BMC
record_format Article
series Nutrition & Metabolism
spelling doaj.art-e32a2b1eea3b4671bd63e223af76c5eb2022-12-22T03:58:02ZengBMCNutrition & Metabolism1743-70752022-10-0119111310.1186/s12986-022-00708-xAnalysis of different adipose depot gene expression in cachectic patients with gastric cancerJun Han0Zuoyou Ding1Qiulin Zhuang2Lei Shen3Fan Yang4Szechun Sah5Guohao Wu6Department of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityAbstract Purpose This study aimed to identify the differentially expressed genes (DEGs) that contributed to the different amount of fat loss between subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) among cachectic patients. Methods RNA sequencing was performed and bioinformatic tools were utilized to analyze the biological functions and construct regulation networks of DEGs. We presumed that iroquois homeobox 1 (IRX1) to be a hub gene and analyzed its clinical significance. Mouse model of cancer cachexia was established and differences between SAT and VAT were compared. The function of IRX1 on lipid metabolism was clarified by Oil Red O staining, qRT-PCR, and Western blotting in adipocytes. Results A total of 455 DEGs were screened between SAT and VAT in cachectic patients. Several hub genes were selected and IRX1 was presumed to contribute to the pathological difference between SAT and VAT in cancer cachexia. Patients with higher expression of IRX1 in SAT than VAT revealed significantly higher weight loss, IL-6 and TNF-α, as well as lower BMI, SAT, and VAT area. IRX1 expression in SAT was negatively correlated with SAT area. In cachectic mice, the expression of IRX1 in SAT was significantly higher than that in VAT. The inhibition effect on adipogenesis exerted by IRX1 was also proved in vitro. Conclusion These data supported that DEGs contribute to the different degrees of fat loss among adipose depots in cachectic patients. IRX1 in SAT promoted fat loss by inhibiting adipocyte differentiation and adipogenesis.https://doi.org/10.1186/s12986-022-00708-xCancer cachexiaAdipose tissue lossSubcutaneous adipose tissueVisceral adipose tissueIroquois homeobox 1
spellingShingle Jun Han
Zuoyou Ding
Qiulin Zhuang
Lei Shen
Fan Yang
Szechun Sah
Guohao Wu
Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
Nutrition & Metabolism
Cancer cachexia
Adipose tissue loss
Subcutaneous adipose tissue
Visceral adipose tissue
Iroquois homeobox 1
title Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
title_full Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
title_fullStr Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
title_full_unstemmed Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
title_short Analysis of different adipose depot gene expression in cachectic patients with gastric cancer
title_sort analysis of different adipose depot gene expression in cachectic patients with gastric cancer
topic Cancer cachexia
Adipose tissue loss
Subcutaneous adipose tissue
Visceral adipose tissue
Iroquois homeobox 1
url https://doi.org/10.1186/s12986-022-00708-x
work_keys_str_mv AT junhan analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT zuoyouding analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT qiulinzhuang analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT leishen analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT fanyang analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT szechunsah analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer
AT guohaowu analysisofdifferentadiposedepotgeneexpressionincachecticpatientswithgastriccancer